Pharsight

Drugs that contain Progesterone

1. Milprosa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10548904 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Feb, 2029

(4 years from now)

US10537584 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Feb, 2029

(4 years from now)

US8580293 FERRING PHARMS INC Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Jan, 2030

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Apr 29, 2023

Market Authorisation Date: 29 April, 2020

Treatment: Method of supporting embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology (art) treatment program for infertile women

Dosage: SYSTEM;VAGINAL

More Information on Dosage

MILPROSA family patents

Family Patents